Insider Profile
Arcuri, Joseph
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
| Date | Company | Dir. | Value |
|---|---|---|---|
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Sell | — |
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Buy | $3K |
| Mar 31, 2026 |
$RX
BioSyent Inc.
|
Buy | $3K |
| Mar 31, 2026 |
$RX
BioSyent Inc.
|
Sell | — |
| Mar 24, 2026 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $697 |
| Dec 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Dec 31, 2025 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $3K |
| Sep 30, 2025 |
$RX
BioSyent Inc.
|
Sell | — |
| Sep 30, 2025 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Jun 30, 2025 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Jun 30, 2025 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2025 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Mar 18, 2025 |
$RX
BioSyent Inc.
|
Buy | — |
| Jan 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $690 |
| Dec 31, 2024 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Dec 31, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2024 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Sep 30, 2024 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Sep 30, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Apr 01, 2024 |
$RX
BioSyent Inc.
|
Buy | $1K |
| Apr 01, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 27, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Jan 02, 2024 |
$RX
BioSyent Inc.
|
Buy | $3K |
| Jan 02, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2023 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Dec 31, 2023 |
$RX
BioSyent Inc.
|
Buy | $770 |
| Oct 02, 2023 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Jun 30, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Jun 30, 2023 |
$RX
BioSyent Inc.
|
Buy | $2K |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2022 |
$RX
BioSyent Inc.
|
Buy | $1K |
| Dec 31, 2022 |
$RX
BioSyent Inc.
|
Buy | $204 |
| Mar 31, 2022 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2021 |
$RX
BioSyent Inc.
|
Buy | $671 |
| Mar 19, 2021 |
$RX
BioSyent Inc.
|
Buy | — |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.